Dr Eu Ro Choo, PSYD | |
10250 Rancho Rd, Adelanto, CA 92301-2732 | |
(760) 561-2158 | |
Not Available |
Full Name | Dr Eu Ro Choo |
---|---|
Gender | Male |
Speciality | Psychologist |
Location | 10250 Rancho Rd, Adelanto, California |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1588158638 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
103T00000X | Psychologist | 10662 (Massachusetts) | Secondary |
103T00000X | Psychologist | PSY29999 (California) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Eu Ro Choo, PSYD 15068 Rosecrans Ave # 310, La Mirada, CA 90638-4740 Ph: () - | Dr Eu Ro Choo, PSYD 10250 Rancho Rd, Adelanto, CA 92301-2732 Ph: (760) 561-2158 |
News Archive
Professor Chris French, has co-authored a paper on sleep paralysis with Julia Santomauro, both of the Anomalistic Psychology Research Unit at Goldsmiths, University of London, which is published in Issue 22 (August 2009) of The Psychologist.
A clinical trial of same-day initiation of antiretroviral therapy (ART) for HIV patients in South Africa led to a higher proportion of people starting treatment and to better health outcomes, according to a new study led by a Boston University School of Public Health researcher.
RaySearch Laboratories AB has entered into a long-term distribution agreement with Hitachi Medical Corporation based in Tokyo, Japan. The agreement means that Hitachi will be fully responsible for marketing, sales and service of RaySearch's proprietary treatment planning system RayStation® on the Japanese market from April 1, 2014.
Nile Therapeutics, Inc., a company focused on the development of novel therapeutics for heart failure patients, today announced that it has completed the dose escalation stage of an ongoing Phase II study of CD-NP in patients with acute decompensated heart failure. Nile had previously announced that the study, NIL-CDNP-CT005, was expanded to permit additional dose exploration prior to proceeding to larger Phase II studies.
A new study reports the virucidal and fusion-inhibiting attributes of snake venom against the COVID-19 agent SARS-CoV-2.
› Verified 8 days ago
Dr. Joseph Dominick Muto, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 10400 Rancho Rd, Adelanto, CA 92301 Phone: 760-561-6100 |